These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
563 related articles for article (PubMed ID: 25162309)
1. Iodine quantification to distinguish clear cell from papillary renal cell carcinoma at dual-energy multidetector CT: a multireader diagnostic performance study. Mileto A; Marin D; Alfaro-Cordoba M; Ramirez-Giraldo JC; Eusemann CD; Scribano E; Blandino A; Mazziotti S; Ascenti G Radiology; 2014 Dec; 273(3):813-20. PubMed ID: 25162309 [TBL] [Abstract][Full Text] [Related]
2. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290 [TBL] [Abstract][Full Text] [Related]
3. Differentiation of renal cell carcinoma subtypes with different iodine quantification methods using single-phase contrast-enhanced dual-energy CT: areal vs. volumetric analyses. Dai C; Cao Y; Jia Y; Ding Y; Sheng R; Zeng M; Zhou J Abdom Radiol (NY); 2018 Mar; 43(3):672-678. PubMed ID: 28721478 [TBL] [Abstract][Full Text] [Related]
4. Quantitative iodine content threshold for discrimination of renal cell carcinomas using rapid kV-switching dual-energy CT. Zarzour JG; Milner D; Valentin R; Jackson BE; Gordetsky J; West J; Rais-Bahrami S; Morgan DE Abdom Radiol (NY); 2017 Mar; 42(3):727-734. PubMed ID: 27847998 [TBL] [Abstract][Full Text] [Related]
5. Tumor grade estımatıon of clear cell and papıllary renal cell carcınomas usıng contrast-enhanced MDCT and FSE T2 weıghted MR ımagıng: radıology-pathology correlatıon. Halefoglu AM; Ozagari AA Radiol Med; 2021 Sep; 126(9):1139-1148. PubMed ID: 34100169 [TBL] [Abstract][Full Text] [Related]
6. Papillary vs clear cell renal cell carcinoma. Differentiation and grading by iodine concentration using DECT-correlation with microvascular density. Marcon J; Graser A; Horst D; Casuscelli J; Spek A; Stief CG; Reiser MF; Rübenthaler J; Buchner A; Staehler M Eur Radiol; 2020 Jan; 30(1):1-10. PubMed ID: 31278580 [TBL] [Abstract][Full Text] [Related]
7. Type 1 papillary renal cell carcinoma: differentiation from Type 2 papillary RCC on multiphasic MDCT. Young JR; Coy H; Douek M; Lo P; Sayre J; Pantuck AJ; Raman SS Abdom Radiol (NY); 2017 Jul; 42(7):1911-1918. PubMed ID: 28265706 [TBL] [Abstract][Full Text] [Related]
8. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography. Coy H; Young JR; Douek ML; Brown MS; Sayre J; Raman SS Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876 [TBL] [Abstract][Full Text] [Related]
9. Differentiation of Clear Cell Renal Cell Carcinoma From Other Subtypes and Fat-Poor Angiomyolipoma by Use of Quantitative Enhancement Measurement During Three-Phase MDCT. Kim SH; Kim CS; Kim MJ; Cho JY; Cho SH AJR Am J Roentgenol; 2016 Jan; 206(1):W21-8. PubMed ID: 26700359 [TBL] [Abstract][Full Text] [Related]
11. Usefulness of rapid kV-switching dual energy CT in renal tumor characterization. Çamlıdağ İ; Nural MS; Danacı M; Özden E Abdom Radiol (NY); 2019 May; 44(5):1841-1849. PubMed ID: 30637472 [TBL] [Abstract][Full Text] [Related]
12. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings. Sun MR; Ngo L; Genega EM; Atkins MB; Finn ME; Rofsky NM; Pedrosa I Radiology; 2009 Mar; 250(3):793-802. PubMed ID: 19244046 [TBL] [Abstract][Full Text] [Related]
13. Sarcomatoid Renal Cell Carcinoma and Collecting Duct Carcinoma: Discrimination From Common Renal Cell Carcinoma Subtypes and Benign RCC Mimics on Multiphasic MDCT. Young JR; Young JA; Margolis DJA; Sauk S; Sayre J; Pantuck AJ; Raman SS Acad Radiol; 2017 Oct; 24(10):1226-1232. PubMed ID: 28528853 [TBL] [Abstract][Full Text] [Related]
14. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma. Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273 [TBL] [Abstract][Full Text] [Related]
15. Imaging features of papillary renal cell carcinoma with cystic change-dominant appearance in the era of the 2016 WHO classification. Honda Y; Goto K; Nakamura Y; Terada H; Sentani K; Yasui W; Sekino Y; Hayashi T; Teishima J; Matsubara A; Fuji T; Kaichi Y; Higaki T; Baba Y; Iida M; Awai K Abdom Radiol (NY); 2017 Jul; 42(7):1850-1856. PubMed ID: 28534069 [TBL] [Abstract][Full Text] [Related]
16. Distribution of renal tumor growth rates determined by using serial volumetric CT measurements. Zhang J; Kang SK; Wang L; Touijer A; Hricak H Radiology; 2009 Jan; 250(1):137-44. PubMed ID: 19092093 [TBL] [Abstract][Full Text] [Related]
17. Characterization of clear cell renal cell carcinoma and other renal tumors: evaluation of dual-energy CT using material-specific iodine and fat imaging. Udare A; Walker D; Krishna S; Chatelain R; McInnes MD; Flood TA; Schieda N Eur Radiol; 2020 Apr; 30(4):2091-2102. PubMed ID: 31858204 [TBL] [Abstract][Full Text] [Related]
18. A practical imaging classification for the non-invasive differentiation of renal cell carcinoma into its main subtypes. Cupido BD; Sam M; Winters SD; Ahmed B; Seidler M; Huang G; Low G Abdom Radiol (NY); 2017 Mar; 42(3):908-917. PubMed ID: 27743018 [TBL] [Abstract][Full Text] [Related]
19. Lesion Size and Iodine Quantification to Distinguish Low-Grade From High-Grade Clear Cell Renal Cell Carcinoma Using Dual-Energy Spectral Computed Tomography. Zhao J; Zhang P; Chen X; Cao W; Ye Z J Comput Assist Tomogr; 2016; 40(5):673-7. PubMed ID: 27224223 [TBL] [Abstract][Full Text] [Related]
20. Differentiation of clear from non-clear cell renal cell carcinoma using CT washout formula. Kopp RP; Aganovic L; Palazzi KL; Cassidy FH; Sakamoto K; Derweesh IH Can J Urol; 2013 Jun; 20(3):6790-7. PubMed ID: 23783049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]